Inhibition of Hypoxia Inducible Factor 1—Transcription Coactivator Interaction by a Hydrogen Bond Surrogate α-Helix

Citations Over TimeTop 10% of 2009 papers

Abstract

Designed ligands that inhibit hypoxia-inducible gene expression could offer new tools for genomic research and, potentially, drug discovery efforts for the treatment of neovascularization in cancers. We report a stabilized alpha-helix designed to target the binding interface between the C-terminal transactivation domain (C-TAD) of hypoxia-inducible factor 1alpha (HIF-1alpha) and cysteine-histidine rich region (CH1) of transcriptional coactivator CBP/p300. The synthetic helix disrupts the structure and function of this complex, resulting in a rapid downregulation of two hypoxia-inducible genes (VEGF and GLUT1) in cell culture.

Related Papers

• → Estrogen Receptor Activation Function 1 Works by Binding p160 Coactivator Proteins(1998)371 cited
• → Estrogen Receptor Activation Function 1 Works by Binding p160 Coactivator Proteins(1998)102 cited
• → Regulation of Nrf2 Transactivation Domain Activity by p160 RAC3/SRC3 and Other Nuclear Co-Regulators(2006)41 cited
• → GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor(2005)37 cited
• → Adeno-Associated Virus Type 2 Rep Protein Inhibits Human Papillomavirus Type 16 E2 Recruitment of the Transcriptional Coactivator p300(2000)24 cited